July 2 (Reuters) - Abzena Plc ABZA.L :
* SIGNED GMP MANUFACTURING AND BIOCONJUGATION AGREEMENTS WITH TELIX PHARMACEUTICALS; AGREEMENTS HAVE A COMBINED VALUE OF $5.9 MILLION
* ABZENA WILL PROGRESS TWO PSMA-TARGETING MONOCLONAL ANTIBODIES FOR PURPOSES OF TARGETED TREATMENT OF METASTATIC PROSTATE CANCER